Generic injectables maker Gland Pharma on February 3 reported a 7% rise in third-quarter profit, as lower expenses helped ...

The company clocked a 4% increase in net profit, which stood at ₹4.53 crore for Q2 of the ongoing financial year. This ...

Despite broader challenges, ASML's backlog remains healthy, and management expects a recovery in H2 2025. Read why ASML stock ...

In an exchange filing last month, the company had informed that a meeting of its Board of Directors is scheduled for this ...

Kamat Hotels (India) hit an upper limit of 20% to Rs 272.55 after reporting robust sequential earnings.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

MercadoLibre has robust growth with significant ad revenue gains. See why MELI stock's high P/E ratio is justified, and why ...

Divi's Labs also said in its exchange filing that it has commenced commercial operations from a part of the Phase 1 of the ...

The stocks of the companies announcing Q3 results will be kept under active watch. Notably, markets have been seeing a ...

Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

Power Grid Corporation of India, Divis Laboratories, Alembic Pharmaceuticals, Aditya Birla Capital, Barbeque-Nation Hospitality, Bombay Dyeing, Castrol India, DOMS Industries, Gateway Distriparks, ...

For three quarters running, Alphabet (Nasdaq: GOOG) (Nasdaq: GOOGL) has surprised and delighted its shareholders with ...